CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang +6 more
wiley +1 more source
Design and Evaluation of a <i>Cinnamomum burmannii</i> Essential Oil-Loaded Preservative Film for Enhancing the Quality and Shelf Life of <i>Squaliobarbus curriculus</i> Filets. [PDF]
Zhang X +5 more
europepmc +1 more source
Laboratory Disinfectants as Preservatives for Helicoverpa armigera Nucleopolyhedrovirus [PDF]
K. Sireesha +4 more
openalex
A 73‐Year‐Old Man With Several Years of Difficulty Climbing Stairs and Frequent Tripping
ABSTRACT A 73‐year‐old man presented with progressive weakness and atrophy predominantly affecting the distal finger flexors and quadriceps muscles. Electrophysiological studies demonstrated mixed myogenic and neurogenic features. Muscle MRI showed inflammatory changes, and muscle biopsy revealed granulomatous myositis with histologic features ...
Mehmet Can Sari +3 more
wiley +1 more source
Decolorized and Undecolorized Ethanol Extracts of Ginggiyang (<i>Leea aequata</i> L.) Leaves as Effective Preservatives of Edible Products. [PDF]
Purwaniati P +3 more
europepmc +1 more source
Neuroinflammation in GAD65 Antibody‐Associated Epilepsy Measured Using [18F]DPA‐714 PET/MRI
ABSTRACT The timing for initiating immunotherapy in patients with glutamic acid decarboxylase 65 (GAD65) antibody‐associated epilepsy is a challenge. We used the translocator protein radioligand [18F]DPA‐714 and PET to evaluate brain microglial activation.
Jingjing Chen +10 more
wiley +1 more source
Evaluation of urinary cfDNA workflows for the molecular profiling of malignant disease. [PDF]
Eberhard A +18 more
europepmc +1 more source
Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher +10 more
wiley +1 more source
Risk assessment of replacing synthetic preservatives with natural ingredients. [PDF]
European Food Safety Authority (EFSA) +9 more
europepmc +1 more source
In a democracy, are some citizens more important than others? [PDF]
Potter, Sharyn J.
core +1 more source

